Ameritas Investment Partners, Inc. Nex Immune, Inc. Call Options Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
About NexImmune, Inc.
- Ticker NEXI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,155,600
- Market Cap $6.04M
- Description
- NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...